uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted October 06, 2006

FDA Warns Mangosteen Juice Maker of Drug Promotions

On September 20, 2006, the U.S. Food and Drug Administration (FDA) sent a Warning Letter to the makers of Xango, a mangosteen juice product. The letter advised that distributors of the product were using brochures making health claims restricted to the promotion of drugs.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at